Copyright Reports & Markets. All rights reserved.

Global Personalized Cancer Medicine Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Personalized Cancer Medicine Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Monoclonal Antibodies
      • 1.4.3 Personalized Cancer Vaccines
      • 1.4.4 Other
    • 1.5 Market by Application
      • 1.5.1 Global Personalized Cancer Medicine Market Share by Application (2014-2025)
      • 1.5.2 Breast Cancer
      • 1.5.3 Lung Cancer
      • 1.5.4 Chronic Myeloid Leukaemia
      • 1.5.5 Bowel Cancer
      • 1.5.6 Other Cancer
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Personalized Cancer Medicine Market Size
    • 2.2 Personalized Cancer Medicine Growth Trends by Regions
      • 2.2.1 Personalized Cancer Medicine Market Size by Regions (2014-2025)
      • 2.2.2 Personalized Cancer Medicine Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Personalized Cancer Medicine Market Size by Manufacturers
      • 3.1.1 Global Personalized Cancer Medicine Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Personalized Cancer Medicine Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Personalized Cancer Medicine Market Concentration Ratio (CR5 and HHI)
    • 3.2 Personalized Cancer Medicine Key Players Head office and Area Served
    • 3.3 Key Players Personalized Cancer Medicine Product/Solution/Service
    • 3.4 Date of Enter into Personalized Cancer Medicine Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Personalized Cancer Medicine Market Size by Type (2014-2019)
    • 4.2 Global Personalized Cancer Medicine Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Personalized Cancer Medicine Market Size (2014-2019)
    • 5.2 Personalized Cancer Medicine Key Players in United States
    • 5.3 United States Personalized Cancer Medicine Market Size by Type
    • 5.4 United States Personalized Cancer Medicine Market Size by Application

    6 Europe

    • 6.1 Europe Personalized Cancer Medicine Market Size (2014-2019)
    • 6.2 Personalized Cancer Medicine Key Players in Europe
    • 6.3 Europe Personalized Cancer Medicine Market Size by Type
    • 6.4 Europe Personalized Cancer Medicine Market Size by Application

    7 China

    • 7.1 China Personalized Cancer Medicine Market Size (2014-2019)
    • 7.2 Personalized Cancer Medicine Key Players in China
    • 7.3 China Personalized Cancer Medicine Market Size by Type
    • 7.4 China Personalized Cancer Medicine Market Size by Application

    8 Japan

    • 8.1 Japan Personalized Cancer Medicine Market Size (2014-2019)
    • 8.2 Personalized Cancer Medicine Key Players in Japan
    • 8.3 Japan Personalized Cancer Medicine Market Size by Type
    • 8.4 Japan Personalized Cancer Medicine Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Personalized Cancer Medicine Market Size (2014-2019)
    • 9.2 Personalized Cancer Medicine Key Players in Southeast Asia
    • 9.3 Southeast Asia Personalized Cancer Medicine Market Size by Type
    • 9.4 Southeast Asia Personalized Cancer Medicine Market Size by Application

    10 India

    • 10.1 India Personalized Cancer Medicine Market Size (2014-2019)
    • 10.2 Personalized Cancer Medicine Key Players in India
    • 10.3 India Personalized Cancer Medicine Market Size by Type
    • 10.4 India Personalized Cancer Medicine Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Personalized Cancer Medicine Market Size (2014-2019)
    • 11.2 Personalized Cancer Medicine Key Players in Central & South America
    • 11.3 Central & South America Personalized Cancer Medicine Market Size by Type
    • 11.4 Central & South America Personalized Cancer Medicine Market Size by Application

    12 International Players Profiles

    • 12.1 Abbott
      • 12.1.1 Abbott Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Personalized Cancer Medicine Introduction
      • 12.1.4 Abbott Revenue in Personalized Cancer Medicine Business (2014-2019)
      • 12.1.5 Abbott Recent Development
    • 12.2 Merck
      • 12.2.1 Merck Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Personalized Cancer Medicine Introduction
      • 12.2.4 Merck Revenue in Personalized Cancer Medicine Business (2014-2019)
      • 12.2.5 Merck Recent Development
    • 12.3 Novartis
      • 12.3.1 Novartis Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Personalized Cancer Medicine Introduction
      • 12.3.4 Novartis Revenue in Personalized Cancer Medicine Business (2014-2019)
      • 12.3.5 Novartis Recent Development
    • 12.4 Amgen
      • 12.4.1 Amgen Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Personalized Cancer Medicine Introduction
      • 12.4.4 Amgen Revenue in Personalized Cancer Medicine Business (2014-2019)
      • 12.4.5 Amgen Recent Development
    • 12.5 Celgene
      • 12.5.1 Celgene Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Personalized Cancer Medicine Introduction
      • 12.5.4 Celgene Revenue in Personalized Cancer Medicine Business (2014-2019)
      • 12.5.5 Celgene Recent Development
    • 12.6 Bayer
      • 12.6.1 Bayer Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Personalized Cancer Medicine Introduction
      • 12.6.4 Bayer Revenue in Personalized Cancer Medicine Business (2014-2019)
      • 12.6.5 Bayer Recent Development
    • 12.7 Roche
      • 12.7.1 Roche Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Personalized Cancer Medicine Introduction
      • 12.7.4 Roche Revenue in Personalized Cancer Medicine Business (2014-2019)
      • 12.7.5 Roche Recent Development
    • 12.8 Astellas
      • 12.8.1 Astellas Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Personalized Cancer Medicine Introduction
      • 12.8.4 Astellas Revenue in Personalized Cancer Medicine Business (2014-2019)
      • 12.8.5 Astellas Recent Development
    • 12.9 Astrazeneca
      • 12.9.1 Astrazeneca Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Personalized Cancer Medicine Introduction
      • 12.9.4 Astrazeneca Revenue in Personalized Cancer Medicine Business (2014-2019)
      • 12.9.5 Astrazeneca Recent Development
    • 12.10 Johnson & Johnson
      • 12.10.1 Johnson & Johnson Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Personalized Cancer Medicine Introduction
      • 12.10.4 Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2014-2019)
      • 12.10.5 Johnson & Johnson Recent Development
    • 12.11 Agilent
    • 12.12 Takeda

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Personalized medicine is at an early stage of development. Scientists found that some cancer cells have particular proteins in the cell and others don’t. Sometimes, cancer cells have far more of a particular protein than healthy cells. Genetic testing of cancer cells and normal cells helps doctors customize treatment to individual patient needs. Personalized treatments may cause fewer side effects than standard options. Some people are already benefiting from this approach.
      In 2018, the global Personalized Cancer Medicine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Personalized Cancer Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Personalized Cancer Medicine development in United States, Europe and China.

      The key players covered in this study
      Abbott
      Merck
      Novartis
      Amgen
      Celgene
      Bayer
      Roche
      Astellas
      Astrazeneca
      Johnson & Johnson
      Agilent
      Takeda

      Market segment by Type, the product can be split into
      Monoclonal Antibodies
      Personalized Cancer Vaccines
      Other

      Market segment by Application, split into
      Breast Cancer
      Lung Cancer
      Chronic Myeloid Leukaemia
      Bowel Cancer
      Other Cancer

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Personalized Cancer Medicine status, future forecast, growth opportunity, key market and key players.
      To present the Personalized Cancer Medicine development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Personalized Cancer Medicine are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now